In order to further understand the molecular mechanism of miR-221-3p regulating the function of AML cells in BMMSC-derived MVs, we proved that miR-221-3p can directly target CDKN1C through bioinformatics analysis and dual-luciferase assay. Here, CDKN1C is linked to acute myeloid leukemia.